LG
CVS icon

LaFleur & Godfrey’s CVS Health CVS Stock Holding History

LaFleur & Godfrey’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,836
Closed -$217K – 146
2024
Q4 		$217K Buy
4,836
+1,610
+50% +$90.3K 0.03% 142
2024
Q3 		$203K Buy
+3,226
New +$188K 0.03% 142
2024
Q2 		– Sell
-4,792
Closed -$382K – 137
2024
Q1 		$382K Sell
4,792
-25,719
-84% -$1.96M 0.06% 103
2023
Q4 		$2.41M Buy
30,511
+705
+2% +$50.2K 0.36% 65
2023
Q3 		$2.08M Buy
29,806
+345
+1% +$24.4K 0.33% 65
2023
Q2 		$2.04M Buy
29,461
+4,217
+17% +$300K 0.31% 65
2023
Q1 		$1.88M Buy
25,244
+2,331
+10% +$195K 0.31% 67
2022
Q4 		$2.14M Buy
22,913
+1,143
+5% +$110K 0.36% 64
2022
Q3 		$2.08M Hold
21,770
– – 0.37% 63
2022
Q2 		$2.02M Sell
21,770
-200
-0.9% -$19.5K 0.32% 68
2022
Q1 		$2.22M Buy
21,970
+120
+0.5% +$12.6K 0.3% 68
2021
Q4 		$2.25M Buy
21,850
+300
+1% +$27.7K 0.29% 71
2021
Q3 		$1.83M Buy
21,550
+1,500
+7% +$126K 0.25% 73
2021
Q2 		$1.67M Buy
+20,050
New +$1.64M 0.24% 75

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LaFleur & Godfrey's CVS Position: Q1 2025 in Review

LaFleur & Godfrey sold out of CVS Health (CVS) in Q1 2025, closing a stake of 4,836 shares — an estimated $217K sold.

LaFleur & Godfrey first reported a position in CVS in Q2 2021 and held it in 14 quarters. The position peaked at $2.41M in Q4 2023. 1,757 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • LaFleur & Godfrey reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • LaFleur & Godfrey sold 4,836 CVS Health shares in Q1 2025, an estimated $217K.
  • LaFleur & Godfrey first reported a position in CVS Health in Q2 2021 and held it in 14 quarters.
  • LaFleur & Godfrey's CVS Health position peaked at $2.41M in Q4 2023.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on LaFleur & Godfrey's 13F filing for Q1 2025, filed 23 Apr 2025.